Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis

CONTEXT: Chronic hepatitis C as well as non-alcoholic fatty liver disease are recognized as the main cause of liver disease in Western countries. It is common to see the concomitance of the diseases and the influence of steatosis in the sustained virological response of patients with hepatitis C virus. OBJECTIVE: Assess the sustained virological response in chronic hepatitis C patients according to the presence of liver steatosis. METHODS: One hundred sixty patients with chronic hepatitis C were retrospectively evaluated. Demographic data such as gender, age, body mass index, presence of diabetes mellitus and systemic arterial hypertension, virus genotype and use of pegylated interferon were analyzed, as was the staging of fibrosis and the presence of steatosis at histology. RESULTS: Most patients were male (57.5%), with a mean age of 48 ± 9.7 years. The most frequent genotype observed was 3 (56.9%) and, in the histological evaluation, steatosis was observed in 65% of the patients (104/160). Sustained virological response in patients with steatosis occurred in 38.5%, and in 32.1% in patients without steatosis (P = 0.54). When we analyzed possible factors associated with the presence of steatosis, only body mass index and systemic arterial hypertension revealed a significant association. When the factors that influenced sustained virological response were evaluated in a logistic regression, genotype and use of pegylated interferon proved to be independent factors associated to the response. CONCLUSION: In the evaluated patients the presence of liver steatosis did not influence the sustained virological response of patients with chronic hepatitis C treated with interferon and ribavirin.

Saved in:
Bibliographic Details
Main Authors: Piccoli,Leonora De Zorzi, Mattos,Angelo Alves de, Coral,Gabriela Perdomo, Mattos,Ângelo Zambam de, Santos,Diogo Edele dos
Format: Digital revista
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032011000300005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-28032011000300005
record_format ojs
spelling oai:scielo:S0004-280320110003000052011-09-12Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosisPiccoli,Leonora De ZorziMattos,Angelo Alves deCoral,Gabriela PerdomoMattos,Ângelo Zambam deSantos,Diogo Edele dos Hepatitis C, chronic Fatty liver Antiviral agents CONTEXT: Chronic hepatitis C as well as non-alcoholic fatty liver disease are recognized as the main cause of liver disease in Western countries. It is common to see the concomitance of the diseases and the influence of steatosis in the sustained virological response of patients with hepatitis C virus. OBJECTIVE: Assess the sustained virological response in chronic hepatitis C patients according to the presence of liver steatosis. METHODS: One hundred sixty patients with chronic hepatitis C were retrospectively evaluated. Demographic data such as gender, age, body mass index, presence of diabetes mellitus and systemic arterial hypertension, virus genotype and use of pegylated interferon were analyzed, as was the staging of fibrosis and the presence of steatosis at histology. RESULTS: Most patients were male (57.5%), with a mean age of 48 ± 9.7 years. The most frequent genotype observed was 3 (56.9%) and, in the histological evaluation, steatosis was observed in 65% of the patients (104/160). Sustained virological response in patients with steatosis occurred in 38.5%, and in 32.1% in patients without steatosis (P = 0.54). When we analyzed possible factors associated with the presence of steatosis, only body mass index and systemic arterial hypertension revealed a significant association. When the factors that influenced sustained virological response were evaluated in a logistic regression, genotype and use of pegylated interferon proved to be independent factors associated to the response. CONCLUSION: In the evaluated patients the presence of liver steatosis did not influence the sustained virological response of patients with chronic hepatitis C treated with interferon and ribavirin.info:eu-repo/semantics/openAccessInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. Arquivos de Gastroenterologia v.48 n.3 20112011-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032011000300005en10.1590/S0004-28032011000300005
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Piccoli,Leonora De Zorzi
Mattos,Angelo Alves de
Coral,Gabriela Perdomo
Mattos,Ângelo Zambam de
Santos,Diogo Edele dos
spellingShingle Piccoli,Leonora De Zorzi
Mattos,Angelo Alves de
Coral,Gabriela Perdomo
Mattos,Ângelo Zambam de
Santos,Diogo Edele dos
Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis
author_facet Piccoli,Leonora De Zorzi
Mattos,Angelo Alves de
Coral,Gabriela Perdomo
Mattos,Ângelo Zambam de
Santos,Diogo Edele dos
author_sort Piccoli,Leonora De Zorzi
title Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis
title_short Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis
title_full Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis
title_fullStr Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis
title_full_unstemmed Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis
title_sort analysis of the sustained virological response in patients with chronic hepatitis c and liver steatosis
description CONTEXT: Chronic hepatitis C as well as non-alcoholic fatty liver disease are recognized as the main cause of liver disease in Western countries. It is common to see the concomitance of the diseases and the influence of steatosis in the sustained virological response of patients with hepatitis C virus. OBJECTIVE: Assess the sustained virological response in chronic hepatitis C patients according to the presence of liver steatosis. METHODS: One hundred sixty patients with chronic hepatitis C were retrospectively evaluated. Demographic data such as gender, age, body mass index, presence of diabetes mellitus and systemic arterial hypertension, virus genotype and use of pegylated interferon were analyzed, as was the staging of fibrosis and the presence of steatosis at histology. RESULTS: Most patients were male (57.5%), with a mean age of 48 ± 9.7 years. The most frequent genotype observed was 3 (56.9%) and, in the histological evaluation, steatosis was observed in 65% of the patients (104/160). Sustained virological response in patients with steatosis occurred in 38.5%, and in 32.1% in patients without steatosis (P = 0.54). When we analyzed possible factors associated with the presence of steatosis, only body mass index and systemic arterial hypertension revealed a significant association. When the factors that influenced sustained virological response were evaluated in a logistic regression, genotype and use of pegylated interferon proved to be independent factors associated to the response. CONCLUSION: In the evaluated patients the presence of liver steatosis did not influence the sustained virological response of patients with chronic hepatitis C treated with interferon and ribavirin.
publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE.
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032011000300005
work_keys_str_mv AT piccolileonoradezorzi analysisofthesustainedvirologicalresponseinpatientswithchronichepatitiscandliversteatosis
AT mattosangeloalvesde analysisofthesustainedvirologicalresponseinpatientswithchronichepatitiscandliversteatosis
AT coralgabrielaperdomo analysisofthesustainedvirologicalresponseinpatientswithchronichepatitiscandliversteatosis
AT mattosangelozambamde analysisofthesustainedvirologicalresponseinpatientswithchronichepatitiscandliversteatosis
AT santosdiogoedeledos analysisofthesustainedvirologicalresponseinpatientswithchronichepatitiscandliversteatosis
_version_ 1756373486478032896